ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.776,47
0,58%
Brent Oil
88,165
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. BioLineRx Ltd (BLRX)

  7. BioLineRx Ltd (BLRX) Notícias

BLRX

BioLineRx (BLRX)

BioLineRx Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLRX
DataHoraFonteTítuloCódigoCompanhia
17/04/202408:00PR Newswire (US)BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual MeetingNASDAQ:BLRXBioLineRx Ltd
04/03/202409:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLRXBioLineRx Ltd
08/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BLRXBioLineRx Ltd
29/12/202318:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BLRXBioLineRx Ltd
29/12/202318:15Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:BLRXBioLineRx Ltd
20/11/202308:25IH Market NewsMonday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and moreNASDAQ:BLRXBioLineRx Ltd
01/11/202308:43PR Newswire (Canada)BioLineRx a conclu un accord de licence exclusive pour le motixafortide en Asie, sous les conseils de MSQ VenturesNASDAQ:BLRXBioLineRx Ltd
31/10/202310:00PR Newswire (Canada)BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. VenturesNASDAQ:BLRXBioLineRx Ltd
26/10/202315:18Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:BLRXBioLineRx Ltd
18/10/202318:07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:BLRXBioLineRx Ltd
11/09/202308:00PR Newswire (US)BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple MyelomaNASDAQ:BLRXBioLineRx Ltd
30/08/202308:16IH Market NewsWednesday’s Wall Street Highlights: Ambarella, Alphabet, Toyota, HP Inc, Vinfast, and moreNASDAQ:BLRXBioLineRx Ltd
23/06/202317:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLRXBioLineRx Ltd
22/03/202308:48Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BLRXBioLineRx Ltd
20/01/202318:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BLRXBioLineRx Ltd
15/11/202214:05TipRanksBioline RX Ltd Sponsored ADR (BLRX) Receives a Buy from H.C. WainwrightNASDAQ:BLRXBioLineRx Ltd
04/11/202217:30PR Newswire (US)BioLineRx Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:BLRXBioLineRx Ltd
28/09/202213:15TipRanksBioline RX Ltd Sponsored ADR (BLRX) Gets a Buy from H.C. WainwrightNASDAQ:BLRXBioLineRx Ltd
20/09/202217:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BLRXBioLineRx Ltd
19/09/202211:53TipRanksBioLineRx (NASDAQ:BLRX) Nosedives on $15M Direct OfferingNASDAQ:BLRXBioLineRx Ltd
09/09/202217:16Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:BLRXBioLineRx Ltd
30/06/202210:42PR Newswire (Canada)BioLineRx conclut une entente de codéveloppement avec GenFleet pour développer davantage le Motixafortide pour le traitement de l'adénocarcinome canalaire pancréatique, selon les conseils de MSQ VenturesNASDAQ:BLRXBioLineRx Ltd
29/06/202209:00PR Newswire (Canada)BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ VenturesNASDAQ:BLRXBioLineRx Ltd
16/03/202212:15TipRanksH.C. Wainwright Thinks Biolinerx’s Stock is Going to RecoverNASDAQ:BLRXBioLineRx Ltd
11/02/202208:50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BLRXBioLineRx Ltd
18/01/202213:40TipRanksBiolinerx (BLRX) Receives a Buy from H.C. WainwrightNASDAQ:BLRXBioLineRx Ltd
21/09/202113:13Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BLRXBioLineRx Ltd
25/02/202108:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLRXBioLineRx Ltd
23/02/202111:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BLRXBioLineRx Ltd
28/01/202113:31TipRanksThese 2 Penny Stocks Could Rally All the Way to $11, Say AnalystsNASDAQ:BLRXBioLineRx Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
LUPA3
LUPATECH ON
BOV
COGN3
COGNA ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados